Scapular fractures osteosynthesis via Judet’s posterior approach: clinical and radiographic results
International Orthopaedics · 2023
DOI: 10.1007/s00264-023-05754-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Orthopaedics, 2023. Verfasst von Emile Dobelle und 5 weiteren Autor:innen. Beteiligte Einrichtung: Département d'Orthopédie Traumatologie du CHU de Toulouse, Hopital Pierre Paul Riquet, Toulouse, France. emile.dobelle@live.com. Hauptthemen laut MEDLINE: Fracture Fixation, Internal, Shoulder Fractures. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Scapular fractures are uncommon and mainly treated nonoperatively. Judet's posterior approach allows access to the fracture site through the infraspinatus fossa and may be a technical option when ORIF is decided. The aims of this study were to determine clinical and radiographic outcomes of patients who underwent scapular body and/or glenoid fractures fixation via Judet's posterior approach. METHODS: We conducted a retrospective single-centre study, and all patients admitted for scapular fracture who underwent osteosynthesis via Judet's approach between January 2014 and September 2021 were included. At a minimum follow-up of one year, clinical outcomes were analyzed through subjective shoulder value (SSV) and Constant-Murley score (CMS). Strength in external rotation was measured in adduction and in 90° abduction and compared to healthy side. Radiographic analysis evaluated postoperative fracture reduction on CT scan and glenohumeral osteoarthritis according to Samilson's classification at last follow-up. RESULTS: Twenty-one patients were included with a mean follow-up of 44.9 months. Mean SSV, CMS, and adjusted CMS were 73.8% ± 21.0, 65.8 points ± 19.5, and 72.8% ± 20.8, respectively. Strength in external rotation in adduction of the affected shoulder showed significant impairment when compared with the contralateral side (respectively 7.79 kg ± 4.29 and 12.0 kg ± 3.84, p = 0.02). All fractures healed uneventfully, but five patients (23.8%) required early revision surgery for intra-articular screws in three. Intra-articular gap measure decreased from 3.75 mm ± 1.93 in preoperative to 0.59 mm ± 0.97 after ORIF. The rate of arthritis was 15% at last follow-up. CONCLUSION: Patients who underwent scapular fracture osteosynthesis via Judet's posterior approach exhibited satisfactory but incomplete recovery of the affected shoulder as evidenced by functional scores and external rotation strength measurements at a mean follow-up of 44.9 months. Because of the risk of intra-articular screws, postoperative CT scan is mandatory.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Département d'Orthopédie Traumatologie du CHU de Toulouse, Hopital Pierre Paul Riquet, Toulouse, France. emile.dobelle@live.com.
- Clinique Universitaire du Sport, Toulouse, France. emile.dobelle@live.com.
- Département d'Orthopédie Traumatologie du CHU de Toulouse, Hopital Pierre Paul Riquet, Toulouse, France.
- Clinique Universitaire du Sport, Toulouse, France.
- Institut de Recherche Riquet (I2R), Toulouse, France.
Zitieren
APA
Dobelle, E., Robert, S., Gaujac, N., Laumonerie, P., Mansat, P., & Bonnevialle, N. (2023). Scapular fractures osteosynthesis via Judet’s posterior approach: clinical and radiographic results. International Orthopaedics. https://doi.org/10.1007/s00264-023-05754-5
Vancouver
Dobelle E, Robert S, Gaujac N, Laumonerie P, Mansat P, Bonnevialle N. Scapular fractures osteosynthesis via Judet’s posterior approach: clinical and radiographic results. International Orthopaedics. 2023. doi:10.1007/s00264-023-05754-5
BibTeX
@article{Dobelle2023,
author = {Dobelle, Emile and Robert, Suzanne and Gaujac, Nicolas and Laumonerie, Pierre and Mansat, Pierre and Bonnevialle, Nicolas},
title = {Scapular fractures osteosynthesis via Judet’s posterior approach: clinical and radiographic results},
journal = {International Orthopaedics},
year = {2023},
doi = {10.1007/s00264-023-05754-5}
}
EUVIMED